PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rheumatology, Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital, Leeds, UK benazir.saleem@nhs.net.\', \'Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, UK.\', \'Rheumatology, Leeds Biomedical Research Centre, Leeds, UK.\', \'Rheumatology, Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital, Leeds, UK.\', \'Transplant and Cellular Immunology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.\', \'Institute of Medical Research at St James\'s University Hospital, University of Leeds, Leeds, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e00205010.1136/rmdopen-2021-002050
?:hasPublicationType
?:journal
  • RMD open
is ?:pmid of
?:pmid
?:pmid
  • 35365569
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.169
?:rankingScore_hIndex
  • 13
is ?:relation_isRelatedTo_publication of
?:title
  • Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all